251 related articles for article (PubMed ID: 37353908)
1. PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis.
Millán-de-Meer M; Luque-Ramírez M; Nattero-Chávez L; Escobar-Morreale HF
Hum Reprod Update; 2023 Nov; 29(6):741-772. PubMed ID: 37353908
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.
Wekker V; van Dammen L; Koning A; Heida KY; Painter RC; Limpens J; Laven JSE; Roeters van Lennep JE; Roseboom TJ; Hoek A
Hum Reprod Update; 2020 Nov; 26(6):942-960. PubMed ID: 32995872
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of 'obesity-associated gonadal dysfunction' in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis.
Escobar-Morreale HF; Santacruz E; Luque-Ramírez M; Botella Carretero JI
Hum Reprod Update; 2017 Jul; 23(4):390-408. PubMed ID: 28486593
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
Cooney LG; Lee I; Sammel MD; Dokras A
Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis.
Bayona A; Martínez-Vaello V; Zamora J; Nattero-Chávez L; Luque-Ramírez M; Escobar-Morreale HF
Hum Reprod Update; 2022 Jun; 28(4):501-517. PubMed ID: 35237802
[TBL] [Abstract][Full Text] [Related]
7. Combined oral contraceptives and/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis.
Luque-Ramírez M; Nattero-Chávez L; Ortiz Flores AE; Escobar-Morreale HF
Hum Reprod Update; 2018 Mar; 24(2):225-241. PubMed ID: 29293982
[TBL] [Abstract][Full Text] [Related]
8. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
9. Circulating kisspeptin and anti-müllerian hormone levels, and insulin resistance in women with polycystic ovary syndrome: A systematic review, meta-analysis, and meta-regression.
Pérez-López FR; Ornat L; López-Baena MT; Santabárbara J; Savirón-Cornudella R; Pérez-Roncero GR
Eur J Obstet Gynecol Reprod Biol; 2021 May; 260():85-98. PubMed ID: 33744505
[TBL] [Abstract][Full Text] [Related]
10. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
Alesi S; Forslund M; Melin J; Romualdi D; Peña A; Tay CT; Witchel SF; Teede H; Mousa A
EClinicalMedicine; 2023 Sep; 63():102162. PubMed ID: 37583655
[TBL] [Abstract][Full Text] [Related]
12. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
13. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.
Pinola P; Lashen H; Bloigu A; Puukka K; Ulmanen M; Ruokonen A; Martikainen H; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Morin-Papunen L
Hum Reprod; 2012 Nov; 27(11):3279-86. PubMed ID: 22933528
[TBL] [Abstract][Full Text] [Related]
14. Negative impact of polycystic ovary syndrome on bone health: a systematic review and meta-analysis.
Piovezan JM; Premaor MO; Comim FV
Hum Reprod Update; 2019 Sep; 25(5):633-645. PubMed ID: 31374576
[TBL] [Abstract][Full Text] [Related]
15. Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women-What Is the Evidence?
Hirschberg AL
J Clin Endocrinol Metab; 2024 Apr; 109(5):1202-1213. PubMed ID: 37886900
[TBL] [Abstract][Full Text] [Related]
16. Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis.
Gunning MN; Sir Petermann T; Crisosto N; van Rijn BB; de Wilde MA; Christ JP; Uiterwaal CSPM; de Jager W; Eijkemans MJC; Kunselman AR; Legro RS; Fauser BCJM
Hum Reprod Update; 2020 Jan; 26(1):103-117. PubMed ID: 31867675
[TBL] [Abstract][Full Text] [Related]
17. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
18. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
19. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
20. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
de Medeiros SF; Rodgers RJ; Norman RJ
Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
